Evidence map›Paper›PMID 34144977›Full record

ArticleScience advances2021

ATM-phosphorylated SPOP contributes to 53BP1 exclusion from chromatin during DNA replication.

Dejie Wang, Jian Ma, Maria Victoria Botuyan, Gaofeng Cui, Yuqian Yan, Donglin Ding, Yingke Zhou, Eugene W Krueger, Jiang Pei, Xiaosheng Wu and 6 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Functional dissection ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Molecular insights for the tumor suppressor role of SPOP in prostate cancer.Biochimica et biophysica acta. Reviews on cancer · 2026
    Review
  7. Article
  8. Ubiquitin System-Driven Proteostasis in DNA Damage Response.International journal of molecular sciences · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Dejie WangDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.ORCID 0000-0003-3870-2385
Jian MaDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.ORCID 0000-0001-9794-4689
Maria Victoria BotuyanDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.ORCID 0000-0002-6466-7432
Gaofeng CuiDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
Yuqian YanDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
Donglin DingDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
Yingke ZhouDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.ORCID 0000-0001-9632-2597
Eugene W KruegerDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.ORCID 0000-0002-1171-9075
Jiang PeiState Key Laboratory of Proteomics, National Center for Protein Sciences, Beijing Institute of Lifeomics, Beijing 102206, China.ORCID 0000-0001-5013-5163
Xiaosheng WuDivision of Hematology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
Liguo WangDivision of Computational Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.ORCID 0000-0003-2072-4826
Huadong PeiGeorge Washington University Cancer Center, Washington, DC 20037, USA.
Mark A McNivenDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA.
Dingwei YeDepartment of Urology, Fudan University Shanghai Cancer Center, Shanghai 200032, China. huang.haojie@mayo.edu mer.georges@mayo.edu dingwei_ye1963@163.com.ORCID 0000-0003-0704-7453
Georges MerDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA. huang.haojie@mayo.edu mer.georges@mayo.edu dingwei_ye1963@163.com.ORCID 0000-0002-1900-1578
Haojie HuangDepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine and Science, Rochester, MN 55905, USA. huang.haojie@mayo.edu mer.georges@mayo.edu dingwei_ye1963@163.com.ORCID 0000-0003-2751-6413
Mayo Clinic · USShanghai Medical College of Fudan University · CNBeijing Proteome Research Center · CNGeorge Washington University · US

Funding

Structural Biology of Lysine Methylation in DNA Damage and Checkpoint SignalingR01CA132878 · NCI · MAYO CLINIC ROCHESTER · PI Georges Mer · 2008 to 2026
$4.5M
Structural biology of DNA damage response in chromatinR35GM136262 · NIGMS · MAYO CLINIC ROCHESTER · PI MER, GEORGES · 2020 to 2025
$4.2M
Role of proinflammatory cytokine-induced AR degradation in castration-resistant prostate cancerR01CA130908 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI HUANG, HAOJIE · 2010 to 2021
$3.5M
Role of FOXO1 Inactivation in Prostate TumorigenesisR01CA134514 · NCI · UNIVERSITY OF MINNESOTA · PI HUANG, HAOJIE · 2009 to 2019
$3.3M
Role of RUNX2 in prostate cancer intratumoral androgen synthesis and progressionR01CA193239 · NCI · MAYO CLINIC ROCHESTER · PI HUANG, HAOJIE · 2015 to 2019
$1.8M
Mechanism and role of aberrant AR activity in castration-resistant prostate cancerR01CA203849 · NCI · MAYO CLINIC ROCHESTER · PI HUANG, HAOJIE · 2018 to 2022
$1.8M
Structural basis of RNF168-mediated ubiquitin signaling at chromosomal DNA breaksR01GM116829 · NIGMS · MAYO CLINIC ROCHESTER · PI MER, GEORGES · 2015 to 2018
$1.3M
NCI NIH HHS R01 CA130908NCI NIH HHS R01 CA132878NCI NIH HHS R01 CA134514NCI NIH HHS R01 CA193239NCI NIH HHS R01 CA203849NIGMS NIH HHS L30 GM134514NIGMS NIH HHS R01 GM116829NIGMS NIH HHS R35 GM136262
6 · The paper itself

Abstract

53BP1 activates nonhomologous end joining (NHEJ) and inhibits homologous recombination (HR) repair of DNA double-strand breaks (DSBs). Dissociation of 53BP1 from DSBs and consequent activation of HR, a less error-prone pathway than NHEJ, helps maintain genome integrity during DNA replication; however, the underlying mechanisms are not fully understood. Here, we demonstrate that E3 ubiquitin ligase SPOP promotes HR during S phase of the cell cycle by excluding 53BP1 from DSBs. In response to DNA damage, ATM kinase-catalyzed phosphorylation of SPOP causes a conformational change in SPOP, revealed by x-ray crystal structures, that stabilizes its interaction with 53BP1. 53BP1-bound SPOP induces polyubiquitination of 53BP1, eliciting 53BP1 extraction from chromatin by a valosin-containing protein/p97 segregase complex. Our work shows that SPOP facilitates HR repair over NHEJ during DNA replication by contributing to 53BP1 removal from chromatin. Cancer-derived SPOP mutations block SPOP interaction with 53BP1, inducing HR defects and chromosomal instability.

Indexed as

ChromatinDNA Breaks, Double-StrandedDNA End-Joining RepairDNA ReplicationNuclear ProteinsRecombinational DNA RepairRepressor ProteinsTumor Suppressor p53-Binding Protein 1ChromatinNuclear ProteinsRepressor ProteinsTumor Suppressor p53-Binding Protein 1

Identifiers

PMID34144977
PMCPMC8213225
OpenAlexW3172847284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.